Cargando…
Dual suppression of inner and outer mitochondrial membrane functions augments apoptotic responses to oncogenic MAPK inhibition
Mitogen-activated protein kinase (MAPK) pathway inhibitors show promise in treating melanoma, but are unsuccessful in achieving long-term remission. Concordant with clinical data, BRAF(V600E) melanoma cells eliminate glycolysis upon inhibition of BRAF(V600E) or MEK with the targeted therapies Vemura...
Autores principales: | Serasinghe, Madhavika N., Gelles, Jesse D., Li, Kent, Zhao, Lauren, Abbate, Franco, Syku, Marie, Mohammed, Jarvier N., Badal, Brateil, Rangel, Cuahutlehuanitzin A., Hoehn, Kyle L., Celebi, Julide Tok, Chipuk, Jerry Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833689/ https://www.ncbi.nlm.nih.gov/pubmed/29348439 http://dx.doi.org/10.1038/s41419-017-0044-1 |
Ejemplares similares
-
Putting the pieces together: How is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy?
por: Elkholi, Rana, et al.
Publicado: (2014) -
FLAMBE: A kinetic fluorescence polarization assay to study activation of monomeric BAX
por: Mohammed, Jarvier N., et al.
Publicado: (2022) -
Activation of the Mitochondrial Fragmentation Protein DRP1 Correlates with BRAF(V600E) Melanoma
por: Wieder, Shira Y., et al.
Publicado: (2015) -
An optimized high-yield protocol for expression and purification of monomeric full-length BAX protein
por: Chen, Yiyang, et al.
Publicado: (2023) -
Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAF(V600E) inhibition and can be targeted to reduce resistance
por: Serasinghe, Madhavika N., et al.
Publicado: (2014)